RECURRENT SOLID TUMOR
Clinical trials for RECURRENT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SOLID TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called LY4052031 in people with advanced or spreading solid tumors, including bladder, breast, lung, and other cancers. The goal is to see if the drug is safe and works against these cancers. About 420 participants will take part, and the study will la…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for kids with Hard-to-Treat cancers: Two-Drug attack on tumors
Disease control Recruiting nowThis study is for children and young adults whose solid tumors have come back or not gone away. It tests two different drug pairs that damage cancer cell DNA to kill the tumor. The goal is to find the best dose and see if the treatment can shrink or stop the cancer.
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Nanoparticle radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called 177Lu-SN201 for people with advanced solid tumors that have not responded to standard therapies. The treatment uses tiny particles that deliver radiation directly to tumors. The goal is to find the safest dose and see if it can shrink tumor…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated May 11, 2026 20:47 UTC